The Long Run with Luke Timmerman podcast

Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

11/12/2024

The Long Run with Luke Timmerman

0:00

1:02:28

Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.

D'autres épisodes de "The Long Run with Luke Timmerman"

Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines
11/12/2024
1:02:28
Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer
25/11/2024
1:00:23
Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools.
Ne ratez aucun épisode de “The Long Run with Luke Timmerman” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.
Ep167: Leslie Williams on transfer RNA therapies
06/11/2024
1:11:28
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
15/10/2024
1:03:35
Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases.
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
26/09/2024
1:02:45
Zach Hornby, CEO of San Diego-based Boundless Bio, on tackling cancer drug resistance.
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
05/09/2024
56:39
Ted Love, chairman of BIO, and Dr. Alan Anderson, executive director of Sickle Forward, on how to improve quality of life for sickle cell disease patients around the world.
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
14/08/2024
1:08:19
Sarah Boyce, CEO of San Diego-based Avidity Biosciences, on RNA medicines for rare muscle diseases.
Ep162: Sean McClain on AI for Biologic Drug Discovery
16/07/2024
1:05:59
Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.
Ep161: Jeff Stein on a Long-Lasting Flu Drug
01/07/2024
1:08:51
Jeff Stein, CEO of San Diego-based Cidara Therapeutics, on a long-lasting drug against flu.
Ep160: Abe Ceesay on Precision Neuroscience
17/06/2024
1:08:48
Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.

Plus d'épisodes

Découvrez le meilleur des podcasts sur l'application GetPodcast.

Abonnez-vous à tous vos podcasts préférés, écoutez les épisodes sans connexion internet et recevez des recommandations de podcasts passionnants.

Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

The Long Run with Luke Timmerman

D'autres épisodes de "The Long Run with Luke Timmerman"

Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer

Ep167: Leslie Williams on transfer RNA therapies

Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity

Ep165: Zach Hornby on Tackling Cancer Drug Resistance

Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients

Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases

Ep162: Sean McClain on AI for Biologic Drug Discovery

Ep161: Jeff Stein on a Long-Lasting Flu Drug

Ep160: Abe Ceesay on Precision Neuroscience